Waldencast's Q1 2025 results showed a 4.1% year-over-year revenue decline, with net loss expanding significantly to $20.7 million. Despite the revenue headwinds, the company maintained strong gross margins and continued investing in marketing to support future growth.
Q1 2025 revenue fell 4.1% year-over-year to $65.4 million
Net loss increased to $20.7 million, largely due to depreciation and financial charges
Milk Makeup revenue declined 15.1% due to tough prior-year comparisons and inventory reductions
Obagi Medical grew revenue 7.1% despite SKU shortages from supply chain restructuring
Waldencast expects stronger performance in the rest of 2025, driven by new product launches, restocking, and improved supply chain operations.
Analyze how earnings announcements historically affect stock price performance